Discontinued — last reported Q2 '22
Medical Essentials — Revenue
Becton, Dickinson and Company Medical Essentials — Revenue decreased by 65.1% to $1.65B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 63.2%, from $4.48B to $1.65B. Over 4 years (FY 2021 to FY 2026), Medical Essentials — Revenue shows a downward trend with a -8.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market demand and successful product adoption, while a decrease may signal competitive pressure or volume declines in core medical supplies.
Detailed definition
This metric represents the total net sales generated by the Medical Essentials business segment, which focuses on high-v...
Peer comparison
Similar to core product revenue segments in other large-cap medical device manufacturers.
bdx_segment_medical_essentials_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.61B | $4.30B | $4.72B | $4.75B | $4.64B | $4.76B | $4.59B | $4.82B | $4.88B | $5.09B | $4.71B | $5.05B | $4.99B | $5.44B | $5.17B | $1.59B | $4.48B | $1.57B | $5.51B | $6.68B | $5.25B | $1.60B | $4.71B | $1.65B |
| QoQ Change | — | -6.6% | +9.7% | +0.7% | -2.3% | +2.6% | -3.7% | +5.1% | +1.2% | +4.3% | -7.5% | +7.2% | -1.1% | +9.0% | -4.9% | -69.3% | +182.5% | -64.9% | +250.2% | +21.3% | -21.4% | -69.6% | +195.5% | -65.1% |
| YoY Change | — | — | — | — | +0.7% | +10.7% | -2.8% | +1.5% | +5.1% | +6.8% | +2.6% | +4.6% | +2.3% | +6.9% | +9.8% | -66.3% | -11.2% | -68.8% | +10.4% | +22.9% | +1.6% | -69.1% | +5.2% | -63.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical essentials — revenue?
- Becton, Dickinson and Company (BDX) reported medical essentials — revenue of $1.65B in Q1 2026.
- How has Becton, Dickinson and Company's medical essentials — revenue changed year-over-year?
- Becton, Dickinson and Company's medical essentials — revenue decreased by 63.2% year-over-year, from $4.48B to $1.65B.
- What is the long-term trend for Becton, Dickinson and Company's medical essentials — revenue?
- Over 4 years (2021 to 2026), Becton, Dickinson and Company's medical essentials — revenue has grown at a -8.8% compound annual growth rate (CAGR), from $19.13B to $13.21B.
- What does medical essentials — revenue mean?
- Total revenue generated specifically by the Medical Essentials business unit.